Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial - Université de Lorraine Access content directly
Journal Articles Clinical Research in Cardiology Year : 2023

Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

Fichier principal
Vignette du fichier
HOMAGE_eGFR_Omics_Paper.pdf (293.37 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03830091 , version 1 (26-10-2022)

Identifiers

Cite

João Pedro Ferreira, John G F Cleland, Nicolas Girerd, Pierpaolo Pellicori, Mark R Hazebroek, et al.. Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial. Clinical Research in Cardiology, 2023, 112 (2), pp.330-332. ⟨10.1007/s00392-022-02116-w⟩. ⟨hal-03830091⟩
19 View
49 Download

Altmetric

Share

Gmail Facebook X LinkedIn More